Supreme Court allows mail-order of abortion pill mifepristone pending appeal
The justices kept FDA mail-order rules in place while Louisiana’s challenge continues, preserving access to a drug used in nearly two-thirds of U.S. abortions.
- On Thursday, May 14, 2026, the Supreme Court preserved access to the abortion drug mifepristone, rejecting lower-court restrictions that would have halted mail-order prescriptions while the legal challenge continues.
- The New Orleans-based 5th U.S. Circuit Court of Appeals ordered the FDA to change rules for the medication on May 1, responding to Louisiana's lawsuit that blocked mail-order access to the drug.
- Danco Laboratories, which manufactures the brand-name version Mifeprex, warned the ruling would be "direct, immediate, and chaotic," preventing patients from picking up prescriptions even in-person at pharmacies.
- Louisiana Attorney General Liz Murrill argued that "hundreds of abortions are occurring every month" in the state despite bans, while Justices Clarence Thomas and Samuel Alito dissented from the emergency order.
- Access will likely remain uninterrupted until next year as the case proceeds, though the FDA is currently reviewing safety protocols that could eventually overturn mail-order availability.
134 Articles
134 Articles
Justices Keep Access to Mifepristone in Place for Now
The Supreme Court on Thursday left nationwide access to the abortion medication mifepristone in place while a legal challenge over the drug progresses. In an unsigned order, the court indefinitely extended a pause on new limits that had been imposed by the 5th US Circuit Court of Appeals, which would...
In the U.S., abortions have been disputed for decades, often even in court. Finally, an instance had banned the sending of an important drug. The Supreme Court of the U.S. decided: Shipping is allowed – but only for a limited period.
'Temporary Relief Isn't Enough,' Advocates Warn After Supreme Court Blocks Abortion Pill Restrictions
"We are relieved that access to mifepristone remains protected for now, but this should never have been on the table in the first place," said one campaigner.
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


























![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)




